BPI
FLNA icon

BFC Planning, Inc.’s Filana Therapeutics FLNA Stock Holding History

BFC Planning, Inc.’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.06K Hold
3,411
– – ﹤0.01% 2750
2026
Q1 		$5.76K Hold
3,411
– – ﹤0.01% 2255
2025
Q4 		$6.75K Hold
3,411
– – ﹤0.01% 2236
2025
Q3 		$9.9K Hold
3,411
– – ﹤0.01% 1927
2025
Q2 		$6.17K Buy
3,411
+2,589
+315% +$4.61K ﹤0.01% 1986
2025
Q1 		$1.23K Hold
822
– – ﹤0.01% 2411
2024
Q4 		$1.94K Buy
+822
New +$14.4K ﹤0.01% 2286

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GMT Capital
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

BFC Planning, Inc.'s FLNA Position: Q2 2026 in Review

BFC Planning, Inc. held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 3,411 shares worth $4.06K. The position accounts for ﹤0.01% of the portfolio, ranked #2750.

BFC Planning, Inc. first reported a position in FLNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.9K in Q3 2025. 87 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • BFC Planning, Inc. held 3,411 shares of Filana Therapeutics worth $4.06K as of Q2 2026.
  • BFC Planning, Inc. left its Filana Therapeutics share count unchanged in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2750 holding.
  • BFC Planning, Inc. first reported a position in Filana Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Filana Therapeutics position peaked at $9.9K in Q3 2025.
  • 87 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.